Immunology
Showing page 109 of 176 pages of list content
-
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection
This article's authors -
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
This article's authors -
Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients
This article's authors -
The percentage of Monocytes CD39+ is higher in Pregnant COVID-19 than in Non-Pregnant COVID-19 patients
This article's authors -
Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
This article's authors -
Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected
This article's authors -
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants
This article's authors -
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2
This article's authors -
SARS-CoV-2 spike RBD and nucleocapsid encoding DNA vaccine elicits T cell and neutralising antibody responses that cross react with variants
This article's authors -
Differences in IgG antibody responses following BNT162b2 and mRNA-1273 Vaccines
This article's authors